Thu 13th Jun 2013 Preliminary results for the year ended 30 April 2013

 

Continuing strong performance and strategic execution

Jon Glenn, Chief Executive Officer, commented:

“This has been a very significant year for Consort Medical in a number of areas: consistent strong financial performance; strategic execution in progressing the development pipeline towards launch; the successful launch of the Chiesi NEXThaler; securing a potentially transformational contract from Nicoventures; and the divestment of King Systems for a full price. We look forward optimistically to continuing strong performance as our strategy continues to deliver.”